Parallel Bio
Drug DiscoveryWebsite
Operator of a biotechnology company intended to design and engineer tools to change the way diseases are cured. The company's platform deploys human immune organoids to rapidly accelerate the discover...
Valuation
$71.5M
Market implied
Share Price
N/A
Total Raised
$24.6M
Last Round
Later Stage VC (Series A1)
Jun 2025
Latest Funding Round
Later Stage VC (Series A1)
Jun 12, 2025
$20M
raised
Investors
+24 other investors